401
Participants
Start Date
April 16, 2019
Primary Completion Date
June 30, 2026
Study Completion Date
February 1, 2028
Daratumumab plus Velcade Cyclophosphamide Dexamethasone
To compare Dara-VCd versus VTd as pre transplant induction and post transplant consolidation, both followed by a maintenance phase with Ixazomib alone or in combination with Daratumumab, in newly diagnosed Multiple Myeloma (MM) young patients eligible for autologous stem cell transplantation.
Velcade Thalidomide Dexamethasone
To compare Dara-VCd versus VTd as pre transplant induction and post transplant consolidation, both followed by a maintenance phase with Ixazomib alone or in combination with Daratumumab, in newly diagnosed Multiple Myeloma (MM) young patients eligible for autologous stem cell transplantation.
A.O.U. Maggiore della Carità di Novara, Novara
University Hospital Ostrava, Ostrava
"General Hospital of Athens Alexandra", Athens
EMN Trial Office S.r.l. Impresa Sociale
OTHER
Stichting European Myeloma Network
NETWORK